Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) (“Salix” or the “Company”) today announced the promotion of William P. Forbes, PharmD to President, Medical, Research and Development and Chief Development Officer.
Dr. Forbes previously served as Executive Vice President, Medical, Research and Development and Chief Development Officer. In his new role, Dr. Forbes’ responsibilities will continue to include the development and post-marketing support of numerous products in a variety of therapeutic indications, including gastroenterology, hepatology and infectious disease. Dr. Forbes will report directly to Thomas W. D'Alonzo upon Mr. D’Alonzo, Acting Chief Executive Officer and Chairman of the Board.
Help employers find you! Check out all the jobs and post your resume.
Dr. Forbes previously served as Executive Vice President, Medical, Research and Development and Chief Development Officer. In his new role, Dr. Forbes’ responsibilities will continue to include the development and post-marketing support of numerous products in a variety of therapeutic indications, including gastroenterology, hepatology and infectious disease. Dr. Forbes will report directly to Thomas W. D'Alonzo upon Mr. D’Alonzo, Acting Chief Executive Officer and Chairman of the Board.
Help employers find you! Check out all the jobs and post your resume.
